Oct 26, 2009 | Drugs.com
Shire Presents Results of Five Lialda (mesalamine) Analyses at ACG 2009 Annual Scientific Meeting
Shire plc , the global specialty biopharmaceutical company, presented the results of three 5-aminosalicylic acid persistency analyses at ACG 2009 Annual Scientific Meeting, evaluating persistency of Lialda , Asacol , Pentasa , balsalazide [combined results from generic balsalazide disodium and Colazal ], and Dipentum .
Treatments for Crohn's disease are many
DEAR DR. DONOHUE: My 22-year-old nephew was diagnosed with Crohn's disease about a year and a half ago.
Also on Topix